EBRT with brachytherapy offers modest survival benefit in prostate cancer

Study shows that intermediate risk prostate cancer patients experience modest benefit from the addition of external beam radiation therapy (EBRT) to brachytherapy.

Read the rest of this entry

Multidisciplinary Cancer Care in Zimbabwe

By David Raben, MD (Originally posted by ASCO) You don’t know what you got until…

Read the rest of this entry

Tuning macrophages a “breakthrough” in cancer immunotherapy

Laurel Lenz, PhD, and colleagues describe “tuning” the body’s macrophages so that instead of aiding cancer growth, they contribute to the immune system’s attack of tumor tissue.

Read the rest of this entry

Richard Bakemeier, well-respected CU Cancer Center member, has passed

We are sad to announce the passing of Richard Bakemeier, MD, a well-respected University of…

Read the rest of this entry

CU Cancer Center researchers earn Transformational Research Funding

Congratulations to University of Colorado Cancer Center investigators who recently earned Transformation Research Funding, awarded by University of Colorado School of Medicine Dean John J. Reilly, Jr., MD.

Read the rest of this entry

The date is set for revamped women’s event

        The University of Colorado Cancer Center is pleased to announce the…

Read the rest of this entry

Libations for Life research funding requests

Since 2010, the University of Colorado Cancer Center has hosted an event to raise research…

Read the rest of this entry

Advances in the treatment of sarcoma

In the last 10 years, there have been tremendous advances in the treatment of lung…

Read the rest of this entry

Center for Human Immune Innovation earns Transformational Research Funding

The University of Colorado School of Medicine will fund a new Center for Human Immune Innovation (CHII), an interdisciplinary program aimed at enhancing CU research in the emerging field of immune therapies.

Read the rest of this entry

In lung cancer, not all HER2 alterations are created equal

Which path leads to HER2 activation in lung cancer? New study by Marileila Garcia, PhD, and colleagues shows that it can be mutation or amplification, but not both.

Read the rest of this entry